By Hirsh Jain via Cannabis Confidential newsletter. Subscribe here. How Zorn’s trajectory from litigator to policymaker echoes Thurgood Marshall. As…
This article originally appeared on IgniteIt and is republished here with permission. The Trump administration’s rescheduling order contains a little-noticed…
The Acting Attorney General is getting the ball rolling on the rescheduling of cannabis from Schedule 1 to Schedule 3,…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov poll found that 59% of…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical…
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of the Controlled Substances Act as…
President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing…
As federal cannabis rescheduling looms on the horizon and more states across the country begin rolling out regulations for legal…
Psychedelic legislation is moving through more state capitols simultaneously than at any point in history. The question is not whether…
A long trail of corruption cases, oversight failures, and drug-war contradictions has left the DEA with a credibility problem, even…